207 related articles for article (PubMed ID: 3762696)
1. A novel selective broad-spectrum anti-DNA virus agent.
De Clercq E; Holý A; Rosenberg I; Sakuma T; Balzarini J; Maudgal PC
Nature; 1986 Oct 2-8; 323(6087):464-7. PubMed ID: 3762696
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
Maudgal PC; De Clercq E; Huyghe P
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
[TBL] [Abstract][Full Text] [Related]
3. Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis.
Votruba I; Bernaerts R; Sakuma T; De Clercq E; Merta A; Rosenberg I; Holý A
Mol Pharmacol; 1987 Oct; 32(4):524-9. PubMed ID: 2823095
[TBL] [Abstract][Full Text] [Related]
4. Selective virus inhibitors.
De Clercq E
Microbiologica; 1990 Apr; 13(2):165-78. PubMed ID: 1693749
[TBL] [Abstract][Full Text] [Related]
5. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
de Clercq E
Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
[No Abstract] [Full Text] [Related]
6. New acquisitions in the chemotherapy of viral infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1990; 52(1):69-99. PubMed ID: 2162118
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses.
Beadle JR; Wan WB; Ciesla SL; Keith KA; Hartline C; Kern ER; Hostetler KY
J Med Chem; 2006 Mar; 49(6):2010-5. PubMed ID: 16539388
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.
De Clercq E; Holý A; Rosenberg I
Antimicrob Agents Chemother; 1989 Feb; 33(2):185-91. PubMed ID: 2719463
[TBL] [Abstract][Full Text] [Related]
9. (S)-9-(2,3-Dihydroxypropyl)adenine: an aliphatic nucleoside analog with broad-spectrum antiviral activity.
De Clercq E; Descamps J; De Somer P; Holý A
Science; 1978 May; 200(4341):. PubMed ID: 205946
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines.
De Clercq E; Sakuma T; Baba M; Pauwels R; Balzarini J; Rosenberg I; Holý A
Antiviral Res; 1987 Dec; 8(5-6):261-72. PubMed ID: 3451698
[TBL] [Abstract][Full Text] [Related]
11. Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK- HSV-1 keratitis in rabbits.
Maudgal PC; De Clercq E
Antiviral Res; 1991 Jul; 16(1):93-100. PubMed ID: 1663731
[TBL] [Abstract][Full Text] [Related]
12. [Possibilities and limits of chemotherapy of diseases caused by herpes simplex and varicella-zoster virus].
Wassilew SW
Hautarzt; 1983 Jan; 34(1):1-5. PubMed ID: 6841073
[TBL] [Abstract][Full Text] [Related]
13. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
[TBL] [Abstract][Full Text] [Related]
14. Stereospecific syntheses of 9-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA).
Holý A; Rosenberg I
Nucleic Acids Symp Ser; 1987; (18):33-6. PubMed ID: 3697146
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of antiviral agents in feline herpetic keratitis: results of an in vitro study.
Williams DL; Fitzmaurice T; Lay L; Forster K; Hefford J; Budge C; Blackmore K; Robinson JC; Field HF
Curr Eye Res; 2004; 29(2-3):215-8. PubMed ID: 15512970
[TBL] [Abstract][Full Text] [Related]
17. Ionic Contra-Viral Therapy (ICVT); a new approach to the treatment of DNA virus infections.
Hartley C; Hartley M; Pardoe I; Knight A
Arch Virol; 2006 Dec; 151(12):2495-501. PubMed ID: 16932984
[TBL] [Abstract][Full Text] [Related]
18. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
